Filtered By:
Specialty: International Medicine & Public Health
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 769 results found since Jan 2013.
Paediatric Inflammatory Multisystem Syndrome and SARS-CoV-2 Infection in Children: Rapid Risk Assessment
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 5/15/2020.
This 18-page report provides details about how several countries affected by the coronavirus disease (COVID-19) pandemic recently reported cases of children who were hospitalized in intensive care due to a rare pediatric inflammatory multisystem syndrome (PIMS). The presenting signs and symptoms are a mix of the ones for Kawasaki disease (KD) and toxic shock syndrome (TSS) and are characterized, among others, by fever, abdominal pain, and cardiac involvement. Risk communication is needed to raise awareness in the medic...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 15, 2020 Category: International Medicine & Public Health Source Type: news
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19): Health Alert Network
Source: Centers for Disease Control and Prevention, Center for Preparedness and Response (CDC CPR). Published: 5/14/2020.
This web page provides background information on several cases of a recently reported multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19); and a case definition for this syndrome. CDC recommends healthcare providers report any patient who meets the case definition to local, state, and territorial health departments to enhance knowledge of risk factors, pathogenesis, clinical course, and treatment of this syndrome.
(Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 14, 2020 Category: International Medicine & Public Health Source Type: news
Coronavirus Anxiety Scale
Source: Christopher Newport University (CNU). Published: 5/14/2020.
Basic information
The coronavirus anxiety scale (CAS) is a self-report mental health screener of dysfunctional anxiety associated with the coronavirus crisis. Because a significant number of people experience clinically significant fear and anxiety during an infectious disease outbreak, the CAS was developed to help clinicians and researchers efficiently identify cases of individuals functionally impaired by coronavirus-related anxiety.
Psychometric properties
Independent studies of adults residing across the United State have demonstrated that the CAS...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 14, 2020 Category: International Medicine & Public Health Source Type: news
Obsession with COVID-19-Scale
Source: Christopher Newport University (CNU). Published: 5/14/2020.
Basic information
The Obsession with COVID-19 Scale (OCS) is a self-report mental health screener of persistent and disturbed thinking about COVID-19. Because the COVID-19 crisis affects nearly every aspect of a person ’s life, the OCS was developed to help clinicians and researchers efficiently identify cases of individuals functionally impaired by their COVID-19 related thinking patterns.
Psychometric properties
The OCS was developed on two large samples of adults (n = 775; n = 398) residing across the United States. The OCS is a reliable instrumen...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 14, 2020 Category: International Medicine & Public Health Source Type: news
Laboratory Biosafety Guidance Related to Coronavirus Disease (COVID-19)
Source: World Health Organization (WHO). Published: 5/13/2020.
The purpose of this 11-page document, updated on May 13, 2020, is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients that meet the case definition of COVID-19.
(PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 13, 2020 Category: International Medicine & Public Health Source Type: news
Fact Sheet for Healthcare Providers: Emergency Use of Infusion Pumps and Infusion Pump Accessories During the COVID-19 Pandemic
Source: U.S. Food and Drug Administration (FDA). Published: 5/13/2020.
This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of infusion pumps and infusion pump accessories. Certain infusion pumps and infusion pump accessories are authorized for emergency use by healthcare providers to treat conditions caused by the coronavirus disease 2019 (COVID-19) with the controlled infusion of medications, total parenteral nutrition (TPN), and/or other fluids.
(PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 13, 2020 Category: International Medicine & Public Health Source Type: news
Member Briefing on Testing, Tracing, and Targeted Containment
Source: U.S. House of Representatives, Committee on Oversight and Reform. Published: 5/13/2020.
This one-hour, 15-minute recording is from the first briefing of the House Select Subcommittee on the Coronavirus Crisis, and features a bipartisan group of key experts on the requirements for safely reopening the nation during the coronavirus pandemic. Panelists have put forward plans to guide federal and state efforts to safely reopen the country, including the AEI Plan, the Hopkins Plan, the Harvard Plan, and the Duke-Margolis Center for Health Policy Plan.
(Video or Multimedia)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 13, 2020 Category: International Medicine & Public Health Source Type: news
Double Jeopardy: COVID-19 and Behavioral Health Disparities for Black and Latino Communities in the U.S.
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 5/12/2020.
This five-page report details how the coronavirus (COVID-19) pandemic has revealed deep-seated inequities in health care for communities of color and amplifies social and economic factors that contribute to poor health outcomes. Recent news reports indicate that the pandemic disproportionately impacts communities of color, compounding longstanding racial disparities.
(PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 12, 2020 Category: International Medicine & Public Health Source Type: news
Factors to Consider When Planning to Purchase Respirators from Another Country: Including KN95 Respirators from China
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/11/2020.
When there is a shortage of NIOSH-approved filtering facepiece respirators (FFRs), as we are experiencing during the coronavirus disease 2019 (COVID-19) pandemic, other reliable options must be found. This web page provides guidance about what to consider when purchasing respirators that meet the regulatory requirements of the countries listed in the FDA ’s Emergency Use Authorization. It details key factors that should assist potential purchasers of international respirators in making informed procurement ...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 11, 2020 Category: International Medicine & Public Health Source Type: news
Coronavirus Disease (COVID-19) FAQs for Wildland Firefighters
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/11/2020.
This web page provides answers to frequently asked questions about wildland firefighters and COVID-19. Topics include how to prevent infection and spread, prioritization of testing, and precautions wildland firefighters should take.
(Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 11, 2020 Category: International Medicine & Public Health Source Type: news
Interim Guidance on Unsheltered Homelessness and Coronavirus Disease 2019 (COVID-19) for Homeless Service Providers and Local Officials
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/10/2020.
This guidance, updated on May 10, 2020, is intended to provide key actions that local and state health departments, homelessness service systems, housing authorities, emergency planners, healthcare facilities, and homeless outreach services can take to protect people experiencing homelessness from the spread of COVID-19 (coronavirus).
(Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 10, 2020 Category: International Medicine & Public Health Source Type: news
Guidance for Law Enforcement and First Responders Administering Naloxone
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 5/8/2020.
This two-page document acknowledges the concerns during the COVID-19 pandemic of first responders and law enforcement officers who have been more reluctant to administer naloxone due to fear of potentially contracting the coronavirus. It makes recommendations to promote first responder safety.
(PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 8, 2020 Category: International Medicine & Public Health Source Type: news
Health Advice for Hot Weather During the COVID-19 Outbreak
Source: World Health Organization, Regional Office for Europe. Published: 5/8/2020.
This one-page fact sheet details how the adverse health effects of hot weather are largely preventable through good public health practice, while also following the advice to protect yourself from coronavirus disease (COVID-19).
(PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 8, 2020 Category: International Medicine & Public Health Source Type: news
COVID-19 and the Use of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers
Source: World Health Organization (WHO). Published: 5/7/2020.
This brief summarizes the current evidence on the impact of angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin receptor blockers on severe acute respiratory illness due to SARS CoV-2. It addresses concerns that ACE inhibitors and angiotensin receptor blockers (ARBs) increase susceptibility to coronavirus SARS CoV-2 (the viral agent that causes the disease COVID-19) and the likelihood of severe COVID-19 illness.
(Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 7, 2020 Category: International Medicine & Public Health Source Type: news
Fact Sheet for Healthcare Providers: Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay
Source: U.S. Food and Drug Administration (FDA). Published: 5/7/2020.
This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay, which received an Emergency Use Authorization from the Food and Drug Administration on May 7, 2020. The Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay is authorized for use on respiratory specimens from individuals suspected of coronavirus disease 2019 (COVID-19) by their healthcare provider.
(PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 7, 2020 Category: International Medicine & Public Health Source Type: news
